Published in Circ Cardiovasc Qual Outcomes on April 24, 2012
Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program. Neurology (2013) 1.44
Stroke Severity Is a Crucial Predictor of Outcome: An International Prospective Validation Study. J Am Heart Assoc (2016) 0.89
Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers. J Am Heart Assoc (2015) 0.84
Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry. Neurology (2016) 0.80
When in rome, do like the Romans: certifying stroke centers with the rod of aesculapius or the medical caduceus of hermes? J Am Heart Assoc (2013) 0.78
Telestroke in an urban setting. Telemed J E Health (2014) 0.75
The Relationships Among Regionalization, Processes, and Outcomes for Stroke Care: A Nationwide Population-based Study. Medicine (Baltimore) (2016) 0.75
Improving thrombolysis for acute ischemic stroke in Lombardia stroke centers. Neurol Sci (2013) 0.75
The American Heart Association's Get With the Guidelines (GWTG)-Stroke development and impact on stroke care. Stroke Vasc Neurol (2017) 0.75
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med (1995) 47.15
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med (2008) 28.42
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation (2008) 4.00
Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology (2005) 2.81
Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke (2011) 2.80
Quality improvement in acute stroke: the New York State Stroke Center Designation Project. Neurology (2006) 2.40
Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation (2010) 2.15
Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients. Stroke (2005) 2.13
Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes (2010) 2.02
Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007. MMWR Surveill Summ (2009) 1.98
Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology (2009) 1.59
Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator. Prehosp Emerg Care (2008) 1.54
Quality of care in women with ischemic stroke in the GWTG program. Stroke (2009) 1.39
Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience. Stroke (2000) 1.35
Thrombolytic therapy for acute stroke--not a moment to lose. N Engl J Med (2008) 1.29
Regional implementation of the stroke systems of care model: recommendations of the northeast cerebrovascular consortium. Stroke (2009) 1.16
A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke (2009) 1.13
Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older. Mayo Clin Proc (2009) 1.12
Stroke center designation can be achieved by small hospitals: the Massachusetts experience. Crit Pathw Cardiol (2008) 1.10
Quality of care and outcomes in patients with diabetes hospitalized with ischemic stroke: findings from Get With the Guidelines-Stroke. Stroke (2010) 1.08
Prehospital care of the acute stroke patient. Tech Vasc Interv Radiol (2005) 1.03
Are quality improvements in the get with the guidelines: stroke program related to better care or better data documentation? Circ Cardiovasc Qual Outcomes (2011) 0.98
Extending the time window for thrombolytic therapy--primum non tardare. Lancet Neurol (2009) 0.78
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation (2008) 4.00
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol (2008) 3.98
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA (2012) 3.07
Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke (2004) 2.92
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke (2013) 2.88
Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol (2007) 2.87
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol (2005) 2.85
Diffusion tensor imaging as potential biomarker of white matter injury in diffuse axonal injury. AJNR Am J Neuroradiol (2004) 2.78
A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74
Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke (2008) 2.72
Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med (2012) 2.64
A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke (2007) 2.63
Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol (2003) 2.41
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation (2010) 2.32
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. J Pathol (2011) 2.27
Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26
Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med (2005) 2.24
Amyloid angiopathy-related vascular cognitive impairment. Stroke (2004) 2.21
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17
Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation (2010) 2.15
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
Hospital-level variation in mortality and rehospitalization for medicare beneficiaries with acute ischemic stroke. Stroke (2010) 2.12
Neuraxial anesthesia in parturients with intracranial pathology: a comprehensive review and reassessment of risk. Anesthesiology (2013) 2.09
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 5-2004 - a 57-year-old man with slurred speech and left hemiparesis. N Engl J Med (2004) 2.04
Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke (2005) 2.03
Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes (2010) 2.02
Peripartum subarachnoid hemorrhage: nationwide data and institutional experience. Anesthesiology (2012) 1.98
Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke (2008) 1.88
Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann N Y Acad Sci (2008) 1.85
Microbleeds versus macrobleeds: evidence for distinct entities. Stroke (2009) 1.83
Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke (2005) 1.83
Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke. Stroke (2014) 1.76
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol (2008) 1.74
Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol (2010) 1.74
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program. Circulation (2010) 1.66
Intracranial subdural hematomas and cerebral herniation after labor epidural with no evidence of dural puncture. Anesthesiology (2006) 1.66
Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction. J Am Coll Cardiol (2012) 1.65
The status of telestroke in the United States: a survey of currently active stroke telemedicine programs. Stroke (2012) 1.65
Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke. Stroke (2011) 1.60
Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program. Arch Intern Med (2008) 1.59
Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke (2012) 1.58
Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator. Prehosp Emerg Care (2008) 1.54
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes (2012) 1.54
The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke (2010) 1.50
Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke. J Am Heart Assoc (2012) 1.48
Off-hour admission and in-hospital stroke case fatality in the get with the guidelines-stroke program. Stroke (2008) 1.48
CT angiographic source images predict outcome and final infarct volume better than noncontrast CT in proximal vascular occlusions. Stroke (2011) 1.48
Cerebral ischemic events associated with 'bubble study' for identification of right to left shunts. Stroke (2009) 1.44
Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke (2012) 1.41
Rapidly progressive renal failure in childhood. Am J Kidney Dis (2002) 1.40
Quality of care in women with ischemic stroke in the GWTG program. Stroke (2009) 1.39
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. Circulation (2004) 1.39
Development of stroke performance measures: definitions, methods, and current measures. Stroke (2010) 1.34
Validation of intracranial area as a surrogate measure of intracranial volume when using clinical MRI. J Neuroimaging (2007) 1.33
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes (2013) 1.31
Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke (2013) 1.28
Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. AJNR Am J Neuroradiol (2002) 1.28
Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke (2008) 1.26